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Simian varicella virus (SVV) causes varicella (chickenpox) in nonhuman primates, becomes latent in cranial and dorsal root
ganglia, and reactivates to produce zoster (shingles). Because the clinical and molecular features of SVV closely resemble
those of varicella zoster virus (VZV) infection of humans, SVV infection of primates has served as an experimental model of
VZV pathogenesis and latency. The SVV genome has been completely mapped, but attempts to clone the 3600-bp EcoRI
fragment located at the leftward end of the virus genome have hitherto been unsuccessful. Herein, we report the cloning and
the complete nucleotide sequence of this region. Comparison of the SVV and VZV sequences in this region revealed an 8-bp
inverted repeat sequence flanking the unique long segment of the SVV genome; an 879-bp open-reading frame (ORF) A in SVV
that is absent in VZV but has 42% amino acid identity to SVV ORF 4 and 49% to VZV ORF 4; a 342-bp ORF B in SVV with 35%
amino acid identity to a 387-bp ORF located to the left of ORF 1 on the VZV genome; and a 303-bp ORF in SVV with 27% amino
acid identity to VZV ORF 1. No homologue of VZV ORF 2 was detected. Transcripts specific for ORFs A and B were present
in SVV-infected cells in culture and in acutely infected monkey ganglia. Overall, there are more than 2000 bp of DNA in the
SVV genome that are absent in the VZV genome. © 2000 Academic Press
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INTRODUCTION
Simian varicella virus (SVV) infection in primates has
clinical, pathological, virological, and immunological fea-
tures similar to those of varicella zoster virus (VZV) in-
fection in humans (Felsenfeld and Schmidt, 1977; Pado-
van and Cantrell, 1986; Clarke et al., 1992; Dueland et al.,
1992). Both SVV and VZV cause primary infection (vari-
cella) at a young age, become latent, and may reactivate
years later to produce shingles (zoster). SVV infection in
primates has proved useful in the study of varicella
pathogenesis and latency (Mahalingam et al., 1991;
Soike, 1992). Both viruses belong to the alphaherpes
family and share extensive DNA homology (Gray and
Oakes, 1984). The SVV genome has been completely
mapped (Clarke et al., 1992; Gray et al., 1992) and con-
ains a unique long (UL) and a unique short (US) segment
with inverted repeat sequences (IRS and TRS) flanking
he US segment (Fig. 1). The nucleotide sequence of the
short segment has been determined (Fletcher and Gray,
1993; Gray et al., 1995). Unlike the 88 bp of IR sequences
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420lanking the UL segment in the VZV genome (Davison and
Scott, 1986), the SVV genome has been reported to lack
repeat sequences flanking the UL segment (Clarke et al.,
1995). Several attempts to clone the SVV EcoRI-I (3600
bp) fragment located at the leftward terminus of the SVV
genome adjacent to the EcoRI-G (6624 bp) fragment
have been unsuccessful. Herein, we cloned and deter-
mined the complete nucleotide sequence of the SVV
EcoRI-I fragment and compared the sequences with the
leftward end of the VZV genome.
RESULTS
Cloning of SVV EcoRI-I fragment
SVV-infected cell DNA has been shown to contain
circular or concatemeric DNA (Clarke et al., 1995). There-
fore, we sequences the ends of the EcoRI-G fragment,
selected nested oligonucleotide primer pairs (3, 4, 5, and
6 in Fig. 1), and used them with primer pairs located at
the rightward end of the SVV genome on the short ter-
minal repeat sequences (TRS) in PCR amplifications. Pri-
ary amplification using SVV-infected cell DNA with
rimers 1 and 6 followed by nested PCR using primers 2
nd 5 did not yield any product. Although primary ampli-ication using primers 1 and 4 did not yield product
etectable by ethidium bromide staining on agarose
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ORFsgels, nested PCR using primers 2 and 3 amplified a
3900-bp DNA fragment. We used GC-melt (Clontech) to
amplify the EcoRI-I fragment (see Materials and Meth-
ods). Therefore, we attribute the lack of primary amplifi-
cation to the high (70%) GC content and the presence of
stable hairpin structures at the termini of the SVV ge-
nome. We cloned the nested PCR fragment into a TA
cloning vector and identified the insert as described
under Materials and Methods.
Sequence analysis of SVV EcoRI-I fragment
We used the cloned SVV EcoRI-I fragment for se-
quence analysis. We determined the nucleotide se-
quence of the ends of the insert using M13 reverse and
T7 promoter primers. We determined the sequence of the
insert primers selected from overlapping sequences.
Based on overlapping sequences determined from both
strands of the SVV EcoRI-I fragment and sequences of
the leftward end from multiple clones, we compiled the
complete sequence of the SVV EcoRI-I fragment. Se-
quence analysis revealed the presence of SVV TRS se-
quences at one end of the SVV insert. We found a 8-bp
sequence (GGCCGGGG) at the leftward end of the SVV
genome that was complementary in the inverse orienta-
tion (CCGGCCCC) to the published sequence of the
UL-IRS junction (Gray et al., 1995) (Fig. 2).
Our sequence analysis determined the size of the SVV
EcoRI-I fragment to be 3600 bp, smaller than the size
predicted earlier (4200–4500 bp) based on migration on
agarose gels (Clarke et al., 1992; Gray et al., 1992). The
iscrepancy in size is probably due to the difference in
he techniques used for size determination. Of the 13
otential ORFs (180–879 bp in size) identified within the
FIG. 1. Amplification and cloning of the 3600-bp SVV EcoRI-I (I)
ragment located at the leftward end of the unique long (UL) segment of
the SVV genome. Based on the published sequence (Gray et al., 1995)
of the inverted repeat sequences (IRS and TRS) of the SVV genome, two
primers (1 and 2) were selected. Nucleotide sequences of either end of
the 6624-bp SVV EcoRI-G (G) fragment were determined and four
primers (3, 4, 5, and 6) were selected. Since the orientation of EcoRI-G
ragment on the SVV genome was unknown, primers 1 and 2 were used
n combination with either 3 and 4 or 5 and 6 in nested PCR amplifi-
ation. Primer “END” was selected and used as a probe to detect the
mplified fragment. Primers 1, 2, 3, and 4 produced a 4000-bp nested
CR product that was cloned into a TA-cloning vector (pCRII).
SIMIAN VARICELLA VIRUSVV EcoRI-I fragment, only four of the SVV ORFs (ORFs A,
, 1, and 3 in Fig. 3) were homologous to VZV ORFs. Theightward end of SVV EcoRI-I encodes the carboxy-ter-
inus of the SVV homologue of VZV ORF 3. Immediately
o the left of ORF 3 on the SVV genome, we identified a
03-bp ORF (ORF 1 in Fig. 3) homologous to the 324-bp
ZV ORF with an amino acid identity of 27%. Like VZV
RF 1, the ATG initiation codon for SVV ORF 1 was also
n an optimal context (23(G)/14(A)) as per Kozak’s rules
Kozak, 1986). No homologue of VZV ORF 2 was present
n SVV. We also identified a 342-bp ORF (ORF B in Fig. 3)
o the left of ORF 1 on the SVV genome. The ATG initia-
ion codon for SVV ORF B is in an optimal context (23(A)/
4(T)) with respect to Kozak’s rules (Kozak, 1986). Our
nalysis of VZV DNA sequences published by Davison
nd Scott (1986) to the left of ORF 1 revealed a hitherto
nidentified 387-bp ORF with 35% amino acid identity to
VV ORF B (Fig. 4). The start codon for VZV ORF B,
ocated at the junction of IRL and UL segments, is also in
n optimal context (23(G)/14(G)) with respect to Kozak’s
ules (Kozak, 1986). Conservation of amino acids be-
FIG. 2. Identification of inverted repeat sequences (TRL and IRL) at
the ends of the unique long (UL) segment of the SVV genome. Se-
quence analysis of the leftward end revealed a 8-bp sequence (GGC-
CGGGG) homologous in the inverse orientation (CCCCGGCC) to the
sequences located at the UL-IRS junction (labeled IRL). The sequences
mmediately to the right of IRL (CCCCCCGG . . .) were homologous in
he inverse orientation to the TRS sequences (. . . CCGGGGGG) located
t the rightward end of the genome. Therefore, these sequences were
dentified as IRS sequences. The location of the unique short (US) and
he flanking inverted repeat (IRS and TRS) sequences on the SVV
genome is shown.
FIG. 3. Sequence organization at the leftward end of the SVV and VZV
genomes. TRL indicates the 8 and 80 bp of terminal repeat sequences
located at the leftward end of the SVV and VZV genomes, respectively.
UL indicates the leftmost parts of the unique long regions of the virus
genomes. SVV ORFs within the 3600-bp SVV EcoRI-I fragment and
homologous to the VZV ORFs are shown. E indicates the EcoRI site
within the coding region for the SVV homologue of VZV ORF 3. ORF B
was assigned based on amino acid sequence similarity between SVV
421AT THE LEFTWARD ENDand VZV sequences upstream of ORF 1. ORF A is present in SVV but not
in VZV, whereas ORF 2 is present in VZV but is absent in SVV.
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4tween the two ORFs was greater at the carboxy-terminus
than at the amino-terminus (Fig. 4).
Unlike the VZV genome, which has only 172 bp be-
tween the leftward end and ORF B, the SVV genome has
2337 bp containing an 879-bp ORF (ORF A in Fig. 3). We
identified a poly(A)-addition signal (AATAAA) approxi-
mately 53 nucleotides downstream from the translational
termination site for SVV ORF A. Analysis of the putative
peptide sequence of ORF A revealed 51% homology to
VZV ORF 4 and 49% homology to SVV ORF 4 (Davison
and Scott, 1986; W. Gray, unpublished obsesrvations)
(Fig. 5). SVV ORF A (879 bp) was smaller than VZV ORF
4 (1356 bp) or SVV ORF 4 (1410 bp). Analysis of all three
reading frames upstream of the ATG codon for SVV ORF
A did not reveal any peptide sequence that was homol-
ogous to VZV ORF 4, thus confirming the absence of
Taq-induced frame-shift errors or splicing. As with ORF
, amino acid conservation was greater in the carboxy-
ermini. One of the histidine residues (position 255) and
wo of the cysteine residues (positions 259 and 264) near
he carboxy-terminus of ORF A were conserved among
he three ORFs (Fig. 5).
Although there were nine other potential ORFs within
he SVV EcoRI-I fragment, we did not detect any signifi-
ant homology between these ORFs and other known
enes in the GenBank database.
resence of ORF A and absence of the VZV ORF 2
omologue in DNA from different strains of SVV
To rule out the possibility that the amplified SVV
coRI-I fragment is a nonspecific PCR product, we used
primer located at the leftward end of the SVV genome,
nd a primer within the SVV EcoRI-G fragment (7 and 11
n Table 1 and Fig. 6) to amplify DNA extracted from
issue culture cells infected with different strains of SVV
Fig. 6B). We amplified the expected 3601-bp fragment
rom each virus strain. PCR amplification with primers
pecific for ORF A (8 and 9 in Fig. 6) yielded the expected
FIG. 4. Predicted amino acid sequence of SVV ORF B and its alignm
ndicated. Highlighted regions indicate identical amino acids in both O
s the initiation codon in both cases.
22 MAHALI71-bp DNA fragment, while primers located within ORFs
and 3 (10 and 11 in Fig. 6) yielded a 631-bp fragment.
l
sThese results confirm the presence of ORF A and the
absence of a VZV ORF 2 homologue in these SVV strains.
Identification of SVV ORF A- and B-specific
transcripts in SVV-infected BSC-1 cells and in ganglia
of a SVV-infected monkey
RT-PCR analysis using oligo(dT) for reverse tran-
scription and SVV ORF A- or B-specific primers for PCR
revealed the 882-bp ORF A and 333-bp ORF B products
in DNAse-treated RNA from infected cells (Fig. 7A).
Similar analysis of pooled RNA extracted from ganglia
of a monkey 11 days after infection, using a different
set of primers that were also specific for SVV ORFs A
or B, also revealed the expected 471- and 170-bp
products using ORF A- and ORF B-specific primers,
respectively. No product was detected when reverse
transcriptase was omitted (Figs. 7A and 7B). The
brightness of the bands in lanes 3 and 4 (from the left)
in Fig. 7B is due to slight overloading of these lanes.
We have observed a single band on other agarose
gels in which these samples were analyzed (data not
shown). These results indicate that both ORFs A and B
are transcribed in SVV-infected cells and in acutely
infected monkey ganglia.
In vitro expression of ORF A protein
We amplified a 970-bp segment encoding the com-
plete SVV ORF A and cloned the product into the pCI-
NEO expression vector. Transcription of the insert in vitro
sing T7 RNA polymerase in a rabbit reticulocyte lysate
evealed a 35-kDa protein that was immunoprecipitated
ith a polyclonal rabbit-anti-SVV antiserum, but not with
reimmune serum (Fig. 8). Although equivalent quanti-
ies of in vitro translated product and immunoprecipitate
ere analyzed, it is not clear why the intensity of the
mmunoprecipitated band was much weaker. Since the
th the predicted sequences of VZV ORF B. Consensus sequences are
umbers on the left indicate the amino acid positions, where number 1
ET AL.ent wi
NGAMane containing immunoprecipitates using normal rabbit
erum (Fig. 8) did not show any band, the 37-kDa band
a
t dicate
cseen in the right most lane is probably not due to a small
fraction of the in vitro translated product left after three
FIG. 5. Predicted amino acid sequence of SVV ORFs 4 and A and alig
t the bottom. Highlighted regions indicate identical amino acids in
ransactivator function of ORF 4 are underlined. Numbers on the left in
ases.
SIMIAN VARICELLA VIRUSwashes. The antiserum might have contained antibodies
specific for the carboxy-terminus of SVV ORF 4 andreacted with the ORF A polypeptide because of the high
degree of homology (Fig. 5). These results show that the
ith the sequences of VZV ORF 4. Consensus sequences are indicated
ee ORFs. The histidine and cysteine residues that are important in
the amino acid positions, where number 1 is the initiation codon in all
423AT THE LEFTWARD ENDnment w
all thr
ORFsORF A encodes a 35-kDa polypeptide that is probably
expressed in SVV-infected cells.
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Molecular analysis of the SVV and VZV genomes has
evealed a nearly identical genome size and molecular
onfiguration (Gray and Oakes, 1984; Clarke et al., 1992).
Several attempts to clone the SVV EcoRI-I fragment by
restriction digestion of virion DNA, isolation of the frag-
TABLE 1
Nucleotide Sequence of the Primers Used in PCR
Primer
number Sequence (59–39)
1 CAATAAAACACGTTGGAACACAG
2 GGATGGCCACTGACTAAA
3 ACATGCACAAAACCAGGTGAC
4 CTCCAACTCCATCGCCGTTATATGGA
5 CGACGTTTAGTTCGTGCACAAGC
6 AGAACATATGGTGCCTGTTCGCGGA
7 TTACACGCTCCCAACCACTCA
8 ACTCTACCAACGTCGTGGTCT
9 CTGGGACGGAGATTAGTAAGT
10 CATTCCGTGTTTCTTGTATCCCAG
11 ACATGCACAAAACCAGGTGAC
12 TCTGACAGTACGAGTCCACT
13 CAGACACGTTCGCTTAGAAG
14 GCCCTACTGTTGAACGCTTC
15 GAATCGCCGCTAATATAACC
16 AATACAAACATGGCCGGGAC
17 GACGTACGAAGAAGCCATCCAAGA
18 AAGGAAAAATGCGGCCGCTTACATTACAGAACGTTCGCT
19 CCGGAATTCT GTGTTTGACG ATACCGGAA
FIG. 6. Presence of ORF A and absence of ORF 2 in different strains
he SVV unique long and unique short segments, respectively. The loc
sed in the PCR are shown. E indicates EcoRI restriction site. (B) DNA
424 MAHALI(b), Washington Regional Primate Center (c), and Delta (d) strains of SVV and
DNA fragments are shown. Molecular weight markers (123 bp and 1 kbp ladment, blunting of ends, and ligation into plasmid vectors
did not yield any recombinant clones. In retrospect, the
high GC content of the leftward terminus of the SVV
genome could have prevented proper blunting and liga-
tion to the vector. Since SVV-infected cell DNA has been
shown to contain circular or concatemeric DNA (Clarke
et al., 1995), we used a PCR-based strategy to amplify a
DNA fragment that spans the leftward and the rightward
termini of the viral genome. Our sequence analysis of
such a fragment localized the leftward end of the SVV
genome to be 3200 bp upstream of the position identified
earlier by Clarke et al. (1995) using a similar amplification
strategy. Their lack of amplification of the full-length
fragment could, once again, have been due to the high
GC content of the TRS sequences and the presence of
airpin structures. If the leftward end of the SVV genome
ere at the location identified earlier (Clarke et al., 1995),
VV would lack homologues for VZV ORF 1, A and B.
nstead, our results demonstrate the presence of tran-
cripts specific for ORFs A and B (Fig. 7) and the pres-
nce of an 8-bp inverted repeat flanking the SVV UL
segment compared to an 80-bp repeat in the VZV ge-
nome (Davison and Scott, 1986). The significance of the
difference between SVV and VZV in the length of the
repeats is unknown.
We found that the SVV EcoRI-I fragment encodes ho-
mologues of VZV ORFs 3 and 1, but no VZV ORF 2
counterpart. We did not detect any size difference in the
PCR fragment that spanned SVV ORFs 3 and 1 using
different strains of the virus. Thus, SVV does not appear
(A) Open and filled boxes indicate inverted repeat sequences flanking
d direction of ORFs A, 1, and 3 and of the primers (7, 8, 9, 10, and 11)
d from BSC-1 cells infected with Hazelton (a), Medical Lake Macaque
ET AL.of SVV.
ation an
extractePCR amplified with the indicated primer pairs. Sizes of the amplified
der) were run for size determination.
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ORFsto have a VZV ORF 2 homologue. We identified two other
ORFs (ORFs A and B) within the SVV EcoRI-I fragment.
Our analysis of published VZV sequences (Davison and
Scott, 1986) revealed the presence of an additional ORF
upstream of ORF 1, homologous to SVV ORF B. However,
we could not find any eukaryotic promoter-like (TATAAA)
FIG. 7. Identification of transcripts specific for SVV ORFs A and B in
irus-infected cells in culture and in ganglia of an acutely infected
onkey. (A) Total RNA (500 ng) extracted from SVV-infected (SVV-
SC-1) or uninfected (BSC-1) BSC-1 cells was reverse-transcribed and
CR-amplified using oligo(dT) primer and primers specific for SVV
RFs A and B in the presence (1) or absence (2) of reverse transcrip-
ase (RT). Products were electrophoresed on an agarose gel and
tained with ethidium bromide. Sizes of the amplified fragments are
ndicated. The left lane shows the molecular weight markers. Tran-
cripts specific for SVV ORFs A and B were present in virus-infected
ells, but not in uninfected cells. (B) Total RNA (3 mg) extracted from
anglia of a monkey acutely infected with SVV was used in a reverse
ranscription reaction (25 ml) in the presence (1RT) or absence (2RT)
of reverse transcriptase using oligo(dT) primers. The reaction product
(2 ml) was used for PCR with primers specific for ORFs A and B. DNA
1 ng) extracted from SVV-infected BSC-1 cells (SVV-BSC-1 DNA) was
sed as a positive control. Sizes of the RT-PCR products are indicated.
SIMIAN VARICELLA VIRUSsequences between the start codon for VZV ORF B and
the leftward end of the virus genome, which may be why
d
wthe ORF was not assigned earlier (Davison and Scott,
1986). Although, we could not locate eukaryotic pro-
moter-like elements upstream of SVV ORF B, we none-
theless detected ORF B-specific transcripts in virus-in-
fected cells in culture and in acutely infected monkey
ganglia.
SVV contains approximately 2000 bp of sequence at
the leftward end that are absent in the VZV genome.
Within these 2000 bp, an 879-bp ORF (ORF A) has a high
degree of amino acid homology (;50%) to both SVV and
VZV ORF 4. Multiple transcripts specific for VZV ORF 4
have been identified and shown to contain co-39-terminal
ends which bypass upstream consensus transcriptional
termination sequences (Kinchington et al., 1994). Further
transcriptional mapping of SVV ORF A is necessary to
determine if a similar pattern of gene expression is used.
The homology among SVV ORF A, SVV ORF 4, and VZV
ORF 4 resides exclusively at the carboxy-termini of the
peptides (Fig. 5). VZV ORF 4 is a transcriptional activator
of diverse target promoters (Perera et al., 1994), including
VZV ORF 62 (Defechereux et al., 1996). The cysteine-rich
carboxy-terminal region of VZV ORF 4 plays a critical role
in trans-regulatory functions (Perera et al., 1994; Moriuchi
et al., 1995). In particular, cysteine-421, cysteine-426, and
histidine-417 are essential for the transactivation func-
tion (Perera et al., 1994). A comparison of SVV ORF A and
VZV ORF 4 showed that the histidine residue and the two
cysteine residues were conserved between the three
polypeptides. When compared to VZV and SVV ORF 4,
FIG. 8. In vitro translation and immunoprecipitation of SVV ORF A
protein. A recombinant clone containing the SVV ORF A in pCI-neo
vector was linearized and transcribed in vitro using T7 RNA polymerase
and translated in vitro using rabbit reticulocyte in the presence of
[35S]methionine (ivt). Translation products were immunoprecipitated
sing either preimmune serum (NRS) or rabbit-anti-SVV antiserum
Anti-SVV), and analyzed on a 10% PAGE-SDS gel followed by autora-
425AT THE LEFTWARD ENDiography. The location of the 35-kDa ORF A protein and molecular
eight markers is shown.
NGAMSVV ORF A lacked the highly acidic amino-terminus (Fig.
4). The first 160 amino acids of VZV ORF 4 are essential
for transactivation of reporter genes that lack complete
polyadenylation signals (Moriuchi et al., 1995). Together,
these observations raise the possibility that SVV ORF A
may lack transactivation function. Further, the amino-
terminus of VZV ORF 4 has been predicted to encode a
nuclear localization signal (Moriuchi et al., 1995). The
absence of these sequences in SVV ORF A may provide
a clue regarding its localization within the virus-infected
cell. VZV ORF 62 is known to influence the transport of
ORF 4 protein into the nucleus (Defechereux et al., 1996).
Studies to examine the protein-protein interactions be-
tween SVV ORFs A and SVV ORF 62 may provide clues to
the role of SVV ORF A in viral infection. As mentioned
above, we do not know if the nine other potential ORFs
that are present within the SVV EcoRI-I fragment are
expressed in virus-infected cells. Taken together, there
are approximately 2000 nucleotides in the SVV genome
that are absent in the VZV genome.
MATERIALS AND METHODS
Cells and viruses
SVV strains were propagated by cocultivation of unin-
fected African green monkey kidney (BSC-1) cells with
SVV-infected cells as described (Gilden et al., 1982).
Primers
We selected oligonucleotide primers including those
listed in Table 1 using DNASIS software (Hitachi Soft-
ware Engineering America), checked for the absence of
hairpins and 39-complementarity, and synthesized
(Sigma-Genosys).
Sequencing of the ends of SVV EcoRI-G fragment
The ends (200 bp) of the insert in a recombinant clone
containing the 6624-bp SVV EcoRI-G fragment (Fig. 1) in
pGEM4 (Promega) were sequenced manually using SP6
and T7 promoter primers and a T7 Sequenase version
2.0 kit (Amersham Life Sciences).
PCR amplification and cloning of SVV EcoRI fragment
We used SVV-infected cell DNA for PCR-amplification
of the EcoRI-I fragment. We selected primers 1 and 2
based on previously published sequences (Gray et al.,
1995) and primers 3, 4, 5, and 6, based on the sequences
from the ends of the SVV EcoRI-G fragment (Table 1, Fig.
2). We used Advantage Taq polymerase with G-C melt
(Clontech) for amplification. PCR conditions included a
denaturation step at 95°C for 30 s, an annealing step at
55°C for 30 s, and a polymerization step at 68°C for 4
min for a total of 35 cycles. The polymerization step in the
426 MAHALIlast cycle was extended to 7 min. Primary amplification
using primers 1 and 6 followed by nested PCR usingprimers 2 and 6 yielded no product, whereas primary
amplification using primers 1 and 4 followed by nested
PCR using primers 2 and 3 amplified a 3900-bp DNA
fragment. We cloned the 3900-bp PCR product into a TA
cloning vector (pCRII; Invitrogen) that contains two EcoRI
sites flanking the TA-cloning site. We confirmed the iden-
tity of the SVV insert by digestion of the recombinant
clone with EcoRI followed by hybridization using radio-
labeled oligonucleotide probes synthesized based on
the published sequence of “END” primer (Clarke et al.,
1995).
Sequencing of SVV EcoRI-I fragment
We determined the nucleotide sequence of the ends of
the SVV EcoRI insert in the pCRII vector using M13
reverse and T7 promoter primers. We determined the
sequence of the insert using primers selected from over-
lapping sequences. We determined the nucleotide se-
quence of SVV EcoRI-I using AmpliTaq DNA polymerase
FS with either the ABI PRISM dye terminator cycle se-
quencing ready reaction kit (402079 from PE Applied
Biosystems) or the dRhodamine terminator cycle se-
quencing ready reaction kit (404043 from PE Applied
Biosystems). Sequencing thermo-cycling parameters
were as follows: denaturation for 5 min at 94°C, 25
cycles of denaturation at 96°C for 10 s, annealing at
50°C for 5 s, and extension/termination at 60°C for 4 min,
followed by incubation at 4°C until the samples were
processed. We analyzed the reaction products on either
an ABI 373A or an ABI Prism 377 DNA fluorescence
sequencer (PE Applied Biosystems). To rule out Taq-
induced errors, we sequenced the GC-rich region lo-
cated at the leftward end from multiple clones. Further-
more, we sequenced the opposite strand of SVV EcoRI-I
fragment to identify and correct any errors noted in the
first strand. We assembled the sequences and identified
SVV ORFs and aligned with VZV ORFs using Vector NTI
Suite software (Informax). We have deposited the com-
plete sequence of the SVV EcoRI-I fragment into Gen-
bank (Accession Number AF236102).
Extraction and PCR amplification of DNA from
multiple SVV strains
We extracted DNA from uninfected BSC-1 cells and
BSC-1 cells infected with different strains of SVV (de-
scribed in Fig. 6 legend) using a commercial genomic
DNA isolation kit (Promega). We used primers 7–11 (Fig.
6, Table 1) with either Advantage Taq polymerase (Clon-
tech) or Taq polymerase (Perkin-Elmer) in PCR under
conditions described above.
Extraction of RNA from SVV-infected BSC-1 cells
We used the RNAzol B (Tel-Test) method for RNA
ET AL.isolation from infected and normal BSC-1 cells. Briefly,
we lysed the cells by addition of RNAzol B directly to cell
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ORFsmonolayers, treated the lysates with chloroform (0.1 ml/
lysate), and centrifuged (12,000 g 3 15 min) and precip-
tated the aqueous layer with isopropanol. We pelleted
he RNA by centrifugation (12,000 g 3 15 min), washed,
esuspended in water, and stored at 270°C.
xtraction of RNA from ganglia of a SVV-infected
onkey
We inoculated a 2-year-old monkey intratracheally
ith 1.8 3 104 PFU of SVV. The animal developed a
idespread hemorrhagic rash and died 11 days after
noculation. We removed the ganglia, pooled them, and
xtracted total RNA using TRIzol reagent (Life Technolo-
ies).
everse transcription (RT)-PCR
We detected transcripts specific for ORF A or B in
ninfected or SVV-infected BSC-1 cells from 0.5 mg of
total cell RNA extracted from the cells using the Access
RT-PCR system (Promega) according to the manufactur-
er’s instructions. ORF A primers (12 and 13 in Table 1)
generated a 879-bp PCR product, and ORF B primers (14
and 15 in Table 1) generated a 333-bp PCR product. We
analyzed the final product on an agarose gel.
For detection of ORF A- or B-specific transcripts in
monkey ganglia, we treated the total RNA with RQ1
RNAse-free DNAse (Promega) until no amplifiable SVV
DNA was detected. We mixed 3 mg of the DNAse-treated
NA with 0.3 mg of oligo(dT) and heated the mixture to
65°C for 5 min and cooled to 43°C before addition of 2 ml
of 10 mM NTPs, 0.5 ml of 10 mg/ml stock of bovine serum
lbumin, 5 ml of 5X RT reaction buffer (Promega), and 10
of AMV reverse transcriptase in a volume of 25 ml. We
incubated the mixture at 43°C for 2 h and then at 95°C
for 5 min to inactivate the RT. We performed the PCR as
described above using 2 ml of the RT product and prim-
ers 8 and 9 (Table 1) to detect ORF A or primers 16 and
17 (Table 1) to detect ORF B. The ORF A primers and ORF
B primers generated a 471- and a 170-bp PCR product,
respectively.
Cloning, in vitro transcription, translation, and
immunoprecipitation of ORF A
We used primer 18 containing a NotI site and primer 19
containing a EcoRI site (Table 1) to PCR-amplify a 970-bp
fragment containing the ORF A coding region from SVV
DNA. We digested the PCR product with NotI and EcoRI,
ligated to pCI-neo (Promega) that had been digested
with NotI and EcoRI, and used them to transform Top10F9
competent cells (Invitrogen). We linearized recombinant
clones containing the ORF A insert using NotI, and used
1 mg of the DNA and T7 RNA polymerase (Life Technol-
gies) to prepare transcripts. We treated the RNA with
SIMIAN VARICELLA VIRUSQ1-DNAse (Promega) and translated in vitro in the
resence of [35S]methionine using the nuclease-treated Gabbit reticulocyte lysate system (Promega). We mixed
he translation product (30 ml) with 20 ml of rabbit anti-
SVV antiserum (Mahalingam et al., 1998) and incubated
at 4°C before addition of 200 ml of 10% protein A-Sepha-
ose beads (Sigma) and further incubation at 4°C for 4 h.
e washed the beads three times with cold immunopre-
ipitate lysis buffer (20 mM Na2HPO4, pH 7.6, 100 mM
aCl, 1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS)
nd resuspended in sample buffer (125 mM Tris-HCl, pH
.8, 6% SDS, 20% glycerol, and 0.01% bromphenol blue).
e analyzed equivalent quantities (;4000 cpm) of the
abeled translation products and the immunoprecipitates
n a 10% polyacrylamide SDS gel followed by autora-
iography.
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